Renovorx to present at ld micro invitational xv conference in new york on april 10th

Mountain view, calif.--(business wire)--renovorx, inc. (“renovorx” or the “company”) (nasdaq: rnxt), a life sciences company developing innovative targeted oncology therapies and commercializing renovocath, a novel, fda-cleared drug-delivery device, today announced that chief executive officer shaun bagai will present at the ld micro invitational xv: new york 2025 conference taking place at the westin grand central hotel, new york, ny on april 10, 2025. mr. bagai will discuss recent corporate m.
RNXT Ratings Summary
RNXT Quant Ranking